Adaptogenics Health Corp. Announces Upcoming Annual General and Special Meeting
Adaptogenics Health Corp. has scheduled its Annual General and Special (AGS) meeting for December 18, 2026, with a record date of November 13, 2026.
Stocks · News reference
An insider at Adaptive Biotechnologies Corporation has sold company shares valued at approximately $879,088.
Reference Details
Poisar stores the source's headline, summary and market tags for reference. Reporting and full article text remain with the original publisher.
Keep reading
Adaptogenics Health Corp. has scheduled its Annual General and Special (AGS) meeting for December 18, 2026, with a record date of November 13, 2026.
TD Cowen analyst Dan Brennan maintains Adaptive Biotechnologies (NASDAQ:ADPT) with a Buy and raises the price target from $28 to $32.
Morgan Stanley analyst Tejas Savant maintains Adaptive Biotechnologies (NASDAQ:ADPT) with a Equal-Weight and raises the price target from $22 to $27.